- ECHA
- Konsultācijas
- Apspriedes par atkāpi no izslēgšanas kritērijiem
- Iepriekšējās apspriedes par atkāpi no izslēgšanas kritērijiem
Iepriekšējās apspriedes par atkāpi no izslēgšanas kritērijiem
Iepriekšējās apspriedes par atkāpi no izslēgšanas kritērijiem
The closed consultations on the derogations to the exclusion criteria as laid down in Article 5(2) of the BPR are listed in the table below.
There are currently no ongoing consultations.
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 8 | 262-104-4 | 60207-90-1 | 17/06/2022 | 15/08/2022 | Details |
2,2-dibromo-2-cyanoacetamide (DBNPA) | PT 6 | 233-539-7 | 10222-01-2 | 03/11/2023 | 04/01/2024 | Details |
2,2-dibromo-2-cyanoacetamide; [DBNPA] | 4 | 233-539-7 | 10222-01-2 | 11/10/2019 | 10/12/2019 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2024 | 25/04/2024 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2018 | 01/04/2018 | Details |
Creosote | PT08 | 232-287-5 | 8001-58-9 | 29/01/2021 | 30/03/2021 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) | 2, 6, 11, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) | 2, 6, 11, 12, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |